Global Inflammatory Bowel Disease Market Research and Forecast 2018-2023

Inflammatory bowel disease (IBD) involves the diseases that cause chronic inflammation of the digestive tract of a human body. The bowel diseases are mainly categorized as Crohn’s disease and Ulcerative colitis. The most probable cause behind such disease is the malfunctioning of immune system or autoimmune disorder leading to damage the healthy cells of digestive tracts. The sedentary life style and the unhealthy food intake is one of the major cause behind the growth of the market. The prevalence of Crohn’s disease and Ulcerative colitis across the world has grown substantially, according to world IBD day a total of 10 million people lives with the disease. The substantial increase in number of patient has also contributed significantly in growth of market. The increased public and private investment in healthcare is propelling the growth in emerging economies. The major factor restraining the growth of the market is high cost of drugs and prolonged treatment tenure. The research and development in novel therapeutics such as stem cell therapy will drive the future market for treatment of IBD (Inflammatory Bowel Disease Market).

Browse full report at: Global Inflammatory Bowel Disease Market

The market is divided into North America, Europe, Asia Pacific and Rest of the World geographically. North America has the largest market of IBD because of large number of patients in the region, the region also has most advanced healthcare infrastructure. The UK in European region holds the second place in prevalence ranking after the US, the region also has well developed infrastructure for healthcare. The APAC region will grow significantly in coming few years due to increase in expenditure for procurement of better healthcare infrastructure.

The competition in IBD market is tough due to the presence of large number of market player, the market players are engaged in providing anti-inflammatory drugs, R&D in the field of novel therapeutics such as stem cell therapy. The Key Players in the inflammatory bowel disease Abbott Laboratories, Amgen, Inc, AstraZeneca PLC, Baxter International Inc., Bristol-Myers Squibb Company, Cosmo pharmaceuticals, Emory healthcare, F. Hoffmann-La Roche AG, Genfit, Innovate Biopharmaceuticals, Janssen Global Services, LLC, Medanta The Medicity, Mylan Pharmaceuticals Ltd., Novartis AG, Pfizer Inc., Pluristem Therapeutics, Inc., Quest diagnostics. The companies are engaged in rapid research and development for the development of effective treatment measure for the disease.

The report covers:

• Comprehensive research methodology of Global Inflammatory Bowel Disease market
• This report also includes detailed and extensive market overview with key analyst insights.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Global Inflammatory Bowel Disease
• Insights about market determinants which are stimulating the Global Inflammatory Bowel Disease
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.
• Related Reports: Healthcare Industry Research

Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts.